Granules India’s Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India has successfully completed the US Food and Drug Administration (FDA) inspection between April 8-12 2024, resulting in zero 483 observations.
This audit was a Pre-Approval Inspection (PAI) and cGMP audit for Active Pharmaceutical Ingredients (APIs) and Formulations (FDs) for oncology and non-oncology products.
The post
You do not have permission to view link please Log in or Register
appeared first on
You do not have permission to view link please Log in or Register